Article info
PDFPaper
Ethics
Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Correspondence to Mr V Cakic, School of Psychology, University of Sydney, Sydney 2006, Australia; vincec{at}psych.usyd.edu.au
Citation
Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
Publication history
- Received May 3, 2009
- Revised June 1, 2009
- Accepted June 2, 2009
- First published September 30, 2009.
Online issue publication
September 30, 2009
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd & Institute of Medical Ethics. All rights reserved.
Other content recommended for you
- Drug use in English professional football
- Would they dope? Revisiting the Goldman dilemma
- Cognitive neuroenhancement: false assumptions in the ethical debate
- Doping is a threat to sporting excellence
- On the argument that enhancement is “cheating”
- A strategy to reduce illicit drug use is effective in elite Australian football
- Expectations regarding cognitive enhancement create substantial challenges
- The use of methylphenidate among students: the future of enhancement?
- Why we should allow performance enhancing drugs in sport
- Neuroenhancers, addiction and research ethics